Last Posted: Nov 21, 2018
- Arrhythmogenic Cardiomyopathy in 2018: ARVC/ALVC or Both?
Bennett Richard G et al. Heart, lung & circulation 2018 Oct - Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations.
Domínguez Fernando et al. Journal of the American College of Cardiology 2018 Nov 72(20) 2471-2481 - Genetic Testing and Counseling for Hypertrophic Cardiomyopathy.
Cirino Allison L et al. Cardiology clinics 2019 Feb 37(1) 35-43 - The Clinical Course of a Genetic Dilated Cardiomyopathy: Letting the Cat Out of the BAG3.
Shaw Robin M et al. Journal of the American College of Cardiology 2018 Nov 72(20) 2482-2484 - Hypertrophic Cardiomyopathy Without Ventricular Hypertrophy: Usefulness of Genetic and Pathological Study in Preventing Sudden Death.
Segura-Villalobos Federico et al. Revista espanola de cardiologia (English ed.) 2017 Jul 70(7) 604-606 - Modeling Hypertrophic Cardiomyopathy in a Dish
NIH Director's Blog, November 8, 2018 - The genetics of hypertrophic cardiomyopathy.
Akhtar Mohammed et al. Global cardiology science & practice 2018 Aug 2018(3) 36 - A stroke gene panel for whole-exome sequencing.
Ilinca Andreea et al. European journal of human genetics : EJHG 2018 Oct - Clinical Outcomes Associated With Sickle Cell Trait: A Systematic Review.
Naik Rakhi P, et al. Annals of internal medicine 2018 11 0. (9) 619-627 - Genotype-Positive Status Is Associated With Poor Prognoses in Patients With Left Ventricular Noncompaction Cardiomyopathy.
Li Shijie et al. Journal of the American Heart Association 2018 Oct 7(20) e009910
No hay comentarios:
Publicar un comentario